We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+8.22%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+468.9%
AUM
$920B
AUM Growth
+$99.4B
Cap. Flow
+$40.5B
Cap. Flow %
4.41%
Top 10 Hldgs %
19.57%
Holding
7,602
New
674
Increased
3,069
Reduced
2,328
Closed
737

Sector Composition

Rank Sector Weight
1 Technology 19.48%
2 Healthcare 10.48%
3 Financials 8.96%
4 Consumer Discretionary 8.42%
5 Industrials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMUX icon
6201
Immunic
IMUX
$178M
$1.02K ﹤0.01%
41
VIRX
6202
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.02K ﹤0.01%
721
REK icon
6203
ProShares Short Real Estate
REK
$11.5M
$1.01K ﹤0.01%
51
+5
+11% +$102
BOXL icon
6204
Boxlight
BOXL
$1.82M
$1K ﹤0.01%
3
-1
-25% -$465
DFJ icon
6205
WisdomTree Japan SmallCap Dividend Fund
DFJ
$374M
$999 ﹤0.01%
+15
New +$1K
NBSE
6206
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$997 ﹤0.01%
+539
New +$1.78K
LNSR icon
6207
LENSAR
LNSR
$64.5M
$995 ﹤0.01%
234
SCPX
6208
DELISTED
Scorpius Holdings, Inc.
SCPX
0
HARP
6209
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$968 ﹤0.01%
136
-8
-6% -$55
ADTX
6210
DELISTED
ADITXT INC
ADTX
0
AYTU icon
6211
AYTU BioPharma
AYTU
$22.3M
$939 ﹤0.01%
+587
New +$1.15K
ACHL
6212
DELISTED
Achilles Therapeutics
ACHL
$935 ﹤0.01%
989
CPRI icon
6213
Capri Holdings
CPRI
$1.82B
$933 ﹤0.01%
26
ACNT icon
6214
Ascent Industries
ACNT
$139M
$918 ﹤0.01%
101
-27
-21% -$257
GNLN icon
6215
Greenlane Holdings
GNLN
$1.06M
0
TKC icon
6216
Turkcell
TKC
$4.7B
$907 ﹤0.01%
254
+202
+388% +$847
PMX
6217
DELISTED
PIMCO Municipal Income Fund III
PMX
$902 ﹤0.01%
112
-1,157
-91% -$9.26K
VTGN icon
6218
VistaGen Therapeutics
VTGN
$9.98M
$899 ﹤0.01%
481
-4,819
-91% -$16.9K
SNCR
6219
DELISTED
Synchronoss Technologies
SNCR
$896 ﹤0.01%
107
LITB
6220
LightInTheBox
LITB
$50.6M
$886 ﹤0.01%
+125
New +$982
LPCN icon
6221
Lipocine
LPCN
$17.1M
$885 ﹤0.01%
177
+1
+0.6% +$5
IBDO
6222
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$885 ﹤0.01%
35
BODI icon
6223
The Beachbody Company
BODI
$71.8M
$870 ﹤0.01%
42
-1,595
-97% -$36.7K
LILM
6224
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$862 ﹤0.01%
490
-26,859
-98% -$25K
GGN
6225
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$762M
$860 ﹤0.01%
230
-64,574
-100% -$241K

Similar funds

JP Morgan Chase's Q2 2023 Portfolio in Review

As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.

  • JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
  • JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
  • JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
  • JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
  • JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
  • JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
  • JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.